Streetbeat News

Products Services

LLY

Eli Lilly's once-weekly insulin efsitora alfa shows non-inferior blood sugar reduction compared to daily insulins in long-term trials. The QWINT-1 and QWINT-3 trials met their primary endpoints, demonstrating similar efficacy to daily insulin glargine and degludec. Despite positive results, LLY stock is down 2.25%.

Portfolio Pulse from Vandana Singh

September 05, 2024 | 1:47 pm

CODX

Co-Diagnostics shares rose after the company announced successful in silico analysis of its Co-Dx Logix Smart Mpox RUO test, confirming its effectiveness against recent mpox strains, including clade 1b.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 1:33 pm

CGC

CURLF

Canopy Growth's subsidiary in Poland is withdrawing its popular medical marijuana strain Penelope due to aging genetics and quality concerns. The company plans to introduce new strains with similar profiles. Meanwhile, Poland's medical marijuana market is booming, with a significant increase in prescriptions and support for decriminalization.

Portfolio Pulse from Nina Zdinjak

September 05, 2024 | 1:32 pm

CODX

Co-Diagnostics has completed an updated analysis of its 2-Gene Mpox RUO Test, confirming that the test retains full reactivity against Mpox strains, including Clade 1b, circulating over the past year.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 1:32 pm

AIQ

AVEM

BABA

Alibaba's Taobao and Tmall platforms now accept WeChat payments, aiming to expand market share in China amid intense competition. This move could help Alibaba grow in less developed regions. Alibaba's stock has declined 13% over the past year. The company also launched a new digital technology company and reported a 4% revenue growth in Q1, missing analyst expectations.

Portfolio Pulse from Anusuya Lahiri

September 05, 2024 | 1:22 pm

GHRS

GH Research PLC (NASDAQ:GHRS), an Irish biotech firm, reported a decline in cash reserves in Q2 2024 while advancing its psychedelic drug trials. The company is conducting trials for its DMT-related drugs, GH001 and GH002, targeting treatment-resistant depression and other psychiatric disorders.

Portfolio Pulse from Jelena Martinovic

September 05, 2024 | 1:22 pm

MULN

Mullen Automotive's subsidiary, Bollinger Motors, has partnered with Texas Consulting & Development to supply B4 Class 4 trucks. This partnership aims to enhance Mullen's vehicle portfolio and expand sales in the commercial, telecom, and utility sectors.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 1:18 pm

SYNX

Silynxcom Ltd. (NYSE:SYNX) has secured three new orders for its tactical communication headsets from law enforcement agencies in Germany and Switzerland. This includes two repeat orders from Switzerland and a new order from Germany, indicating growing demand for their products in Europe.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 1:16 pm

PSTX

RHHBY

Poseida Therapeutics is set to present new clinical data from its Phase 1 study of the allogeneic CAR-T therapy P-BCMA-ALLO1 at the International Myeloma Society Annual Meeting. The initiation of a Phase 1b trial has generated a $20 million payment from Roche.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 1:14 pm

PRGS

Progress Software has released the Progress MarkLogic Server, which significantly improves response accuracy and simplifies the development of secure AI-enhanced applications.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 1:12 pm